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Over 40 years of studies in the field of higher eukaryotic translation are summarized in the review. Among the
pioneer results obtained we should especially accentuate the following: i) discovery of the adaptation of tRNAs
and aminoacyl-tRNA synthetases (ARSs) cellular pools to the synthesis of specific proteins and modulation of
the elongation rate by rare isoacceptor tRNAs; ii) the chaperone-like properties of the translation components
(ribosomes and elongation factor eEF1A); characterization of high molecular weight complexes of ARSs; iii)
functional compartmentalization, including channeling of tRNA in eukaryotic cells; iv) molecular mechanisms
of channeling mediated by different non-canonical complexes involving eEF1A, tRNA and aminoacyl-tRNA syn-
thetases; v) characterization of the crystal structure of eEF1A2; vi) comparison of spatial structure, molecular
dynamics, tyrosine phosphorylation and abilities to interact with different protein partners of the eEF1A1 and
eEF1A2 isoforms; vii) discovery of the microRNA-mediated control of the expression of the proto-oncogenic
eEF1A2 isoform in cancer cells; viii) examination of the cancer-related changes in translation elongation comp- 
lex eEF1H and mechanisms of oncogene PTI-1 action; ix) discovery of the third tRNA binding site on mammals
ribosomes and the allosteric interaction of the 80S ribosomal A and E sites.
Keywords: protein biosynthesis, higher eukaryotes, tRNA, aminoacyl-tRNA synthetases, compartmentalization,
channeling, eEF1A, microRNAs, eEF1H, ÐÒ²-1, 80S ribosomes. 
Protein biosynthesis is a major cellular process provi-
ding decoding and realization of genetic information.
In general it is an intrinsic attribute of all living orga-
nisms and has common characteristics. However, from
the very beginning the main translational components
and molecular mechanisms were studied solely on pro-
karyotic objects. Nowadays, it is clear that in spite of
the common overall picture of protein biosynthesis the- 
re are some specific peculiarities of the process in high- 
er eukaryotes.
We had started to investigate the molecular mecha-
nisms of translation of genetic information on mamma-
lian objects 40 years ago with a focus on tRNA and ami- 
noacyl-tRNA synthetases (ARSs). First, we were inte-
rested whether a set of tRNAs and ARSs, i. e. a ratio of
individual molecules in a total cellular pool, is constant or
variable depending on the cell functioning and phy-
siological or pathological conditions of an organism sub-
sistence. One of the appropriate model systems to study 
this question was considered the mammary gland which
undergoes striking structural and functional changes.
Consequently, in full lactation period protein synthesis
in the mammary gland is extraordinary rapid and inten-
sive and mainly two specific milk proteins are produ-
ced. A comparison of tRNA and ARS pools in mamma- 
ry gland of virginal, lactating and non-lactating cows
resulted in discovery of so called «functional adapta-
tion of tRNA and ARS to the synthesis of specific pro-
teins» [1–3]. The essence of this phenomenon is that at
full lactation the ratio of some individual tRNA and ARS
changes to correspond to the amino acid composition
the main milk proteins. Moreover, we had found the
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changes in isoacceptor spectrum of individual tRNAs
as well, e. g. the appearance of a new minor component
of leucyl-tRNAs during the production of the specific
proteins, which disappears in the dry period. Since
publication of our pioneer results indicating the tRNA
functional adaptation, the phenomenon was described
for several other specialized tissues not only in mam-
mals [4, 5]. Later, it was found that tRNA and ARS adap-
tation was of great importance for regulating the inten-
sity and rate of certain protein production. Moreover,
the appearance (or considerable raise) of some isoaccep- 
tor species of tRNA may switch on the translation of
mRNA containing some rare codon corresponding to
the anticodon of this individual tRNA. So called «adap- 
tor-modification» hypothesis of protein biosynthesis re-
gulation at the translation level was proposed on the
basis of such data and experimentally proved [4, 5].We
had managed to demonstrate the regulatory function of
tRNA using tRNA-dependent cell-free system of protein 
biosynthesis and tissue explants from lactating rabbit
mammary gland [6]. The level and rate of both total pro-
tein and caseins synthesis were much higher in the pre-
sence of homologous tRNA from lactating gland in
comparison with tRNA from dry mammary, rabbit liver
or yeast. Moreover, the stimulation of specific milk pro-
teins production was observed under addition of tRNA
from lactating gland to the incubation medium with the
gland explants of pregnant rabbits. 
The basic principles of gene expression control in
higher eukaryotes at the translation level were formula- 
ted in the review [7] devoted to the facts and hypothe-
ses of protein synthesis regulation in higher eukaryo-
tes. Special attention was paid to the translation regu-
lation as one of the most important components of chan-
ging or interfering with the cell program in such proces-
ses as growth, development, malignant transformation,
and apoptosis.
The situation with ARSs is similar, their synthesis
and amount in eukaryotic cells is not constitutive and
not synchronized depending on the functional state of an 
organism and physiological or pathological conditions of
its operation. Thus, the adaptation of ARS pool to the
amino acid composition of mainly synthesized proteins 
was found at the differentiation of mammary gland and in
regenerating liver [8–10]. Moreover, some particular al-
terations were shown for leucyl-tRNA synthetase (LeuRS)
in differentiated (lactating) mammary gland. Today we
may assume that the increase in amount and catalytic
activity of the enzyme is connected not only with a high 
content of leucine in milk proteins but also with the fact 
that LeuRS according to recent data is a leucine sensor
for TORC1 in both yeast and mammalian cells [11]. It
is well known that TORC1 is a central regulator of cell
growth in response to amino acid availability.
It is of great interest that study on mammalian ARSs
opened a new phase in our research on structural and
functional organization of the translation apparatus as a 
whole unit and consequently on compartmentalization
of protein biosynthesis in higher eukaryotes. The exis-
tence of multisynthetase complexes, affinity of essen-
tially all ARSs to the ribosomal RNA, linkage of various
translational components with the cytoskeleton and en- 
doplasmic reticulum evidence specific organization of
protein synthesis apparatus as a basis for compartmen-
talization of protein biosynthesis in higher eukaryotes.
On this account several directions of experimental in-
vestigations were developed by us, namely – study on
large ARSs complexes, tRNA/aatRNA channeling and
interactions of ARS with ribosome and elongation factor
eEF1A. We studied large ARSs complexes (codosomes
or high-Mr), first described by Deutscher [12], in diffe-
rent mammalian tissues under different conditions and
found that codosomes contained not only majority of
ARSs but methyltransferase, protein kinases activities,
tRNA and several phospholipids as well [13–16]. Im-
portantly, there were not found protease and ribonuc-
lease activities. The composition of high-Mr complexes 
at different intensity and rate of protein synthesis corres- 
ponded in general to the total cytoplasmic pool of their
constituents which seems to reflect the principles of lar-
ge complexes formation. 
The high-Mr complexes are associated inside the cell 
with rough endoplasmic reticulum and polyribosomes.
It is suggested that the affinity of the eukaryotic ARSs
to high-molecular weight rRNA serves their localiza-
tion on polyribosomes [17]. The association of ARS
with polyribosomes is rather labile and is shown to chan- 
ge at the functional and pathological states that differ in
the intensity of protein synthesis in the eukaryotic cell
[18]. The association of the higher eukaryotic ARSs, ini- 
tiation and elongation factors with polyribosomes and
membranes seems to enable the compartmentalization of 
ELSKAYA A. V. ET AL. 
the translational machinery, thereby enhancing the effi-
ciency of its operating. 
A question arose as to the functional role of the
ARSs association with polyribosomes. Some results
were reported indicating the influence of ribosomes on
the catalytic activity of ARS, however, these data were
rather contradictory and fragmentary. We provided more
detailed investigation of the functional meaning of the
ARS–ribosome interaction and discovered the undoub- 
ted effect of rabbit liver ribosomes on the catalytic pro-
perties and thermal stability of homologous LeuRS,
involved in the high-Mr complex, and phenylalanyl-
tRNA synthetase (PheRS) which is not a component of
this complex. Study on thermal stability gave us ground
to think that 80S ribosomes could stabilize an active
conformation and promote the renaturation of the mam-
malian ARSs.
This line of research was explored further in long-
standing collaboration with Marc Mirande’s group.
Subcellular localization of the multi-aminoacyl-tRNA
synthetase complex (MARS) in human cells was exa-
mined. The cellular mobility of several synthetases, as-
sessed by measuring fluorescence recovery after photo-
bleaching, demonstrated that they are not freely diffu-
sible within the cytoplasm. Several of these enzymes,
isolated by tandem affinity purification, were co-puri-
fied with ribosomal proteins and actin. The capacity of
ARSs to interact with polyribosomes and with the actin
cytoskeleton was shown to impact their subcellular
localization and mobility [19]. Evolutionary aspects of
multisynthetase complex formation were studied taking
as an example Nematoda Caenorhabditis elegans [20].
This organism was shown to evolve a specific structu-
ral organization of this complex, which contains several
components of the MARS complexes known so far, but 
also displays significant variations. These data highlight
molecular evolution events that took place after radia-
tion of bilaterians. Remarkably, it shows that expansion
of MARS assembly in metazoans is not linear, but is
the result of additions and subtractions along evolution.
Another translational component the ARS interac-
tion with which is of special importance is elongation
factor 1A (eEF1A) and the meaning of such relation-
ship is closely related to the tRNA channeling, which
was discovered during stay of B. Negrutskii in the labo- 
ratory of prof. Deutscher [21]. It appeared that protein
biosynthesis in mammalian cells is a channeled path-
way – aa-tRNA, the intermediate in the process, is di-
rectly transferred from ARS to the elongation factor,
and then to ribosome without dissociation into cellular
fluid [22]. It was revealed that aa-tRNA and tRNA
were never free in the cytoplasm of the eukaryotic cell
[21, 22]. In our research, first of all, we found that rab-
bit eEF1A could stimulate the phenylalanyl-tRNA syn- 
thetase activity, the effect being specific towards the
origin of tRNA and elongation factor molecules [23]. 
 Later it was confirmed for other ARSs, moreover,
in addition to activation eEF1A was shown to promote
the renaturation of ARSs and protect them against de-
naturation e. g. by dilution [24]. Remarkably, in vitro re-
naturation was observed at the molar ratio of eEF1A to
ARS equivalent to that found in the cytoplasm of higher
eukaryotic cells. We suggested a direct interaction bet-
ween these two key translational components and con-
cluded that the chaperone-like activity of eEF1A might
be important for maintaining the enzymes activity and
stability in the protein synthesis compartments of mam-
malian cells. Furthermore, according to the proposed
scheme of channeling, ARS and eEF1A are the partners 
ensuring the transport of tRNA/aa-tRNA from ARS to
the factor, then to the ribosomal A site and from E site
via the factor back to ARS to be re-aminoacylated. If
our hypothesis was correct eEF1A should interact not
only with ARS but with both free and charged tRNA
rather strongly.
Eukaryotic EF1A was well known to interact in GTP- 
bound form with aa-tRNA promoting its binding to the
ribosome. However, another ternary complex [eEF1A ⋅
GDP ⋅ deacylated tRNA], had never been considered in
widely recognized elongation schemes. We postulated
the formation of this unusual complex in [23], and later
detected it by four independent methods [25]. 
The formation of eEF1A ⋅ GDP ⋅ tRNA complex was 
shown for several non-charged individual tRNAs, and
Kd of the complexes were calculated. Of interest is a re-
latively high affinity of eEF1A to deacylated tRNAs in
comparison with the prokaryotic system. No comple-
xes were formed between any tRNA of different origin
with prokaryotic EF1A. To check the universality of
formation of non-orthodox complexes for eukaryotes
the possibility of their formation of yeast and rabbit
eEF1A ⋅ GDP with several deacylated tRNAs was stu-
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died by a band shift assay and confirmed by a FRET
fluorescence technique. For the first time we have shown
the ability of yeast eEF1A ⋅ GDP to form non-canonical
ternary complex with deacylated tRNAs. It is of great
interest that eukaryotic eEF1A ⋅ GDP can also form
complex with deacylated initiator tRNA with stability
equal to that of the complex with elongator tRNAs.
Moreover, it was demonstrated the principal possibility 
of high affinity association between translation initia-
tion factor eIF2 ⋅ GDP with deacylated initiator tRNAi
Met.
These data altogether strongly support the idea of uni-
versality of molecular mechanisms of aa-tRNA/tRNA
channeling in protein synthesis in eukaryotic cells. 
The channeling presumes transfer of a substrate «from
hand to hand», in case of tRNA from ARS to eEF1A
and vice versa. Does it mean that the active partners of
the channeling process interact with each other direct-
ly? The possibility of ARS–EF1A interaction was stu-
died in vitro using rabbit liver eEF1A, PheRS and valyl-
tRNA synthetase (ValRS)-eEFlH complex. eEF1A cau-
sed 2-fold stimulation of both ValRS and PheRS forma-
tion. The stimulation was rather specific since BSA and 
bacterial factor EF-Tu had no stimulatory capacity. Ne- 
vertheless, the mechanisms of eEF1A-induced stimula- 
tion were quite different for two synthetases. Stimula-
tion of ValRS required GTP strongly suggesting the clas-
sical ternary complex ValRS-GTP-eEF1A involvement
[26]. On the contrary, activation of PheRS can be indu-
ced by GDP form of eEF1A as well [23]. Moreover, the 
stimulatory effect was observed already at the level of
phenylalanine activation, suggesting factor-synthetase
interaction to occur at some step before aminoacyl-tRNA
dissociation. It gives grounds to propose a special func- 
tional role for eEF1A ⋅ GDP, namely, to form eEF1 ⋅ GDP ⋅
tRNA complex and to deliver deacylated tRNA to ARS.
The idea was confirmed by obtaining the quaternary
complexes of two spesifisities – [PheRS ⋅ EF-lA ⋅ GDP ⋅
tRNAPhe] and [SerRS ⋅ EF-lA ⋅ GDP ⋅ tRNASer] using «band
shift» technique [27].
On the basis of these findings a model of translation 
apparatus functioning is developed which suggests
eEF1A to be a shuttle between ribosome and hypotetic
macromolecular complex of ARSs and eEF1H [28, 29].
In summary, the concept of functional compart-
mentalization of mammalian translation apparatus has
been put forward. Functional compartmentalization is
the formation of labile protein–protein and protein–
RNA complexes which provide organization of the
translation compartments and their efficient functio-
ning, in particular, tRNA channeling. The definition for
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Channeling of initiator and elon-
gator tRNAs for higher eukaryo-
tic protein synthesis: 1 – forma- 
tion of ternary complex amino-
acyl-tRNA ⋅ eEF1A ⋅ GTP; 2 –
eEF1A ⋅ GDP is formed after GTP
hydrolysis; 3 – eEF1A ⋅ GDP in- 
teracts with deacylated tRNA; 4 –
eEF1A ⋅ GDP can pick up deacy-
lated initiator tRNA after the ini-
tiation step is completed; 5 – ini- 
tiator methyonyl-tRNA can be
channeled to the initiation site
by eIF2 ⋅ GTP; 6 – eEF1B ex-
changes GDP for GTP in eEF1A
molecule; 7 – aminoacyl-tRNA
is synthesized by aminoacyl-
tRNA synthetase; 8 – amino-
acyl-tRNA is transferred from
aminoacyl-tRNA synthetase to
eEF1A ⋅ GTP
translational compartment is as follows: it is an assemb-
ly of macromolecular complexes which are dynamical-
ly converted during mRNA translation in some limited
space [29]. The proposed scheme of tRNA channelling
as a main feature of the protein synthesis compartment
is given in Figure.
Besides the specific function of eEF1A in transla-
tion the factor is known as a moonlighting protein par-
ticipating in many important cellular processes [28]. It
is an actual challenge to understand the molecular basis 
of multifunctional behavior of eEF1A and interaction
with many partners of different nature. 
Structural studies on prokaryotic EF1A (formerly
EF-Tu) involved in the various complexes with GDP or 
GTP/GDPPNP, aa-tRNA, and the exchange factor EF1B
have provided an almost complete understanding of the 
molecular details of the EF1A functioning beyond the
ribosome. The crystal structure of the protein comple-
xed with GDP is known for trypsin-modified and nati-
ve EF1A. The EF1A molecule consists of three distinct
globular domains, connected by flexible interconnec-
ting peptides, like beads on a string. The three domains
form a flattened triangular shape of 7.5 by 5.0 by 3.0 nm.
X-ray data have been published for the yeast eEF1A
(molecular mass 50 kDa) crystallized in a complex with a
fragment of the nucleotide-exchanging subunit eEF1Bα
(molecular mass 11 kDa) [30]. As expected, eEF1A
contained three structural domains similar to bacterial
EF1A. Until we have recently obtained and resolved
the crystal structure of rabbit liver EF1A [31] there was
no information on the crystal or solution structure of
mammalian eEF1A. It was not known how the confor- 
mation of eEF1A may be affected by its interaction
with tRNA either. To address the issues, we analyzed
the structure of both rabbit liver eEF1A ⋅ GDP and its
complex with tRNA in solution by the neutron scatte-
ring and microcalorimetry methods. We found that
rabbit liver eEF1A had a considerably more disorde-
red conformation than its prokaryotic analogue. The
conformation of eEF1A became significantly more com-
pact during the interaction with tRNA [32]. The eEF1A
molecule was hypothesized to adopt an extended con-
formation due to the loss of the association between
domains I and III. The interaction was renewed upon
addition of the biological ligand (tRNA) leading to sig-
nificant compactization of the protein. 
However, for a complete picture we needed a crystal
structure of the factor. It is necessary to remind that two 
tissue- and development-specific isoforms of eEF1A
have been identified, the properties of eEF1A1 and
eEF1A2 will be thoroughly discussed below. In 2012 for
the frst time, in collaboration with laboratory of prof.
M. Tukalo we successfully crystallized one of the iso-
forms of mammalian factor [31], and investigated the
crystal structure of the naturally folded and post-trans-
lationally modified eEF1A2 ⋅ GDP complex from rabbit 
liver (Oryctolagus cuniculus) at 2.6 C resolution. Impor- 
tantly, this complex is 100 % identical to its human ho-
mologue. The overall structure of eEF1A2 ⋅ GDP is typi-
cal for the EF-Tu/EF1A family, however, several unique
structural features of eEF1A2 ⋅ GDP comparing to eubac-
terial and archaebacterial analogs are demonstrated. The
principal difference between the mechanisms of the GDP/ 
GTP exchange in the prokaryotic and higher eukaryotic 
elongation factors are described in details (in prepara-
tion). Further research will show whether the isoform
eEF1A1 differs from eEF1A2 in this respect and how
much if YES.
Two isoforms of eEF1A are about 98 % similar
though encoded by different genes with different expres-
sion patterns. The expression of the isoforms is mutual- 
ly exclusive: eEF1A1 is expressed in all tissues throu-
ghout development but is absent in adult muscle and
heart. The latter tissues express instead eEF1A2 as do
certain other cell types including, notably, large motor
neurons, islet cells in the pancreas and enteroendocrine
cells in the gut. Since eEF1A2 is present in skeletal myo-
cytes, cardiomyocytes and neurons and eEF1A1 in all
remaining cells of the adult organism [33] a role of the
isoforms in translation should be principally the same
while tissue specific localization suggests a possibility
of their different moonlighting functions. The most
significant difference is connected with participation of 
the factor’s isoforms in the essential cellular processes,
while eEF1A2 is related to carcinogenesis, eEF1A1 is
found to stimulate apoptosis [34]. eEF1A2 is found to
be overexpressed in a number of human cancers [35–37]
and shows in some cases oncogene-like properties [38– 
41]. It remains mysterious in what way eEF1A2, 98 %
similar and 92 % identical to eEF1A1, which is specific 
for a definite tissue, may be related to the formation of
tumor in the same tissue. 
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The eEF1A1 and eEF1A2 isoforms are known to
contain 462 and 463 amino acid residues correspon-
dingly with 34 replacements and sole deletion of penul- 
timate residue in eEF1A1. eEF1A1 has seven modified
residues as eEF1A2 is characterized by four modified
residues [42]. We supposed that even slight difference
of primary sequences may cause significant differences 
of spatial structures of the eEF1A isoforms affecting, in 
its turn, the ability of one or another isoform to interact
with protein partners which may result in the modifica-
tion of its known functions and appearance of some new
ones. The differential scanning microcalorimetry and
circular dichroism in «near» and «far» UV regions were
used to compare the spatial structures of two tissue-spe-
cific eEF1A isoforms. It appeared that the potentially
oncogenic eEF1A2 isoform possessed a more compact
spatial organization than eEF1A1, and the differences
were revealed at the levels of both secondary and ter-
tiary structure of proteins. These specificities of spatial
organization may result in the exposure of functional si-
tes in eEF1A2, capable of binding signal molecules,
which may serve as one of the reasons for oncogenicity
of this isoform.
Since tyrosine kinases are prominent players in
cancer development, direct comparison of the ability
of eEF1A1 and eEF1A2 to be involved in phosphoTyr- 
specific signalling processes could help to interpret can-
cer-related properties of eEF1A2. The ability of eEF1A1
and eEF1A2 to interact with SH2 and SH3 domains of
different signalling molecules in vitro was compared as 
well as the levels of their tyrosine phosphorylation. To
test if native eEF1A1 and eEF1A2 contain such modifi- 
cations we probed the isolated eEF1A proteins with mo-
noclonal antibodies specific to phosphorylated tyrosi-
nes. Actually, A2 isoform of mammalian translation
factor eEF1A was found to display increased tyrosine
phosphorylation and ability to interact with different
signaling molecules [43] that may be connected with its 
oncogenic-like property. A possible role of tyrosine
phosphorylation in providing the background for struc- 
tural differences between the «extended» A1 isoform
and the compact A2 isoform is discussed in [44]. In ge-
neral dynamic changes in post-translational modifica-
tions play a central role in regulation of cell signaling in 
both normal and pathological processes and could be
vital for organisms. Very often, the signaling processes
comprise subsequent phosphorylation/dephosphory-
lation of the tyrosine, serine and threonine residues in
regulatory proteins, which is a central subject of cur-
rent phosphoproteomic studies and reviewed in [45].
The current knowledge about «structure–function»
relationship in macromolecules gives grounds for con-
sidering one more reason of the functional difference
between eEF1A1 and eEF1A2 that might lie in changes 
of the isoforms molecular dynamics. We used bioinfor- 
matics approach and determined by multiple MD simu- 
lation that eEF1A1 shows increased reciprocal flexibi-
lity of structural domains I and II and less average dis-
tance between the domains, while increased non-corre-
lated diffusive atom motions within protein domains
characterize eEF1A2. The divergence in the dynamic
properties of eEF1A1 and eEF1A2 is caused by interac-
tions of amino acid residues, that differ between the
two variants, with neighboring residues and water envi-
ronment. The main correlated motion of both protein
isoforms is the change in proximity of domains I and II
which can lead to disappearance of the gap between the
domains and transition of the protein into a «closed»
conformation. 
Such a transition is reversible and the protein can
adopt an «open» conformation again [42]. This finding
is in line with our earlier experimental observation that
the transition between «open» and «closed» conforma-
tions of eEF1A could be essential for binding of tRNA
and/or other biological ligands. For example, the puta-
tive calmodulin-binding region Asn311-Gly327 is less
flexible in eEF1A1 implying its increased affinity for
calmodulin which is a messenger protein. The ability of
eEF1A1 rather than eEF1A2 to interact with Ca2+/cal-
modulin is shown experimentally in an ELISA-based
test [42, 46].
These works are among the first studies suggesting
that 98 % similar isoforms of homologous proteins may 
have different spatial conformations [47] and molecu-
lar dynamics [42]. Therefore, not only the changes in the 
primary structure, revealed e. g. in the appearance of new
domains, or in elimination or appearance of new sites of
post-translational modifications, but also the changes in
their spatial conformation are important for the func-
tional divergence of the protein isoforms. These data
will allow extending the direction of searching for mul- 
tiple families of various isoproteins.
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One of the cardinal tasks is to discover the mecha-
nisms of differential regulation of the eEF1A isoforms ex- 
pression. As it was noted, that during postnatal period a 
switch from eEF1A1 to eEF1A2 expression occurs in
the cardiac, muscle and neuronal tissues. This change
of their expression is crucial, as the mice with a partial
deletion of the gene die on the 28th day after birth [33].
At cancerogenesis the appearance of EEF1A2 in non-
specific tissues and its overexpression in tumor tissues
was found not to be a consequence of any multiplica-
tion of gene loci that might arise from chromosome in-
stability, or from genetic and/or epigenetic changes [40,
48], thus suggesting the possibility of the regulation oc- 
curring at the post-transcriptional level. To solve the
problem, at least partly, several model systems were used,
including breast cancer progression [49] and myoblast
differentiation [50]. The research on these two models
was performed in close collaboration with laboratory of 
prof. A. Harel-Bellan. Despite high homology in an open
reading frame (ORF) region, mRNAs coding for eEF1A1
and eEF1A2 are different in their untranslated regions
(UTR), suggesting a possibility of their dissimilar post-
transcriptional regulation. To analyze the existence of cis- 
acting motifs in the UTRs of EEF1A1/A2 mRNAs an en-
semble of bioinformatic methods was applied to predict 
regulatory motifs in the UTRs of EEF1A1/A2 mRNAs. 
Dual-luciferase reporter assay was also employed to 
detect post-transcriptional regulation of eEF1A1/A2 ex-
pression. Numerous regulatory motifs in the UTR of
EEF1A1/A2 mRNAs were found bioinformatically,
though, these mRNAs contain distinct motifs in the
UTRs. The experimental evidence was obtained for the 
existence of negative regulation of EEF1A1 and positi-
ve regulation of EEF1A2 mRNA in the model of breast 
cancer development. The results suggest that in cancer
the expression of EEF1A isoforms is regulated in a diffe-
rent way at post-transcriptional level and is controlled
by different cellular signals [49]. 
Using immortalized human myoblasts cell line
LHCN, we have shown the induction of isoform A2 of
eEF1 during differentiation of myoblasts. The existence
of transcriptional and post-transcriptional control of the 
above-mentioned process was confirmed. Downregula-
tion of microRNAs, mir-661 and mir-744, that have bin-
ding sites in the 3'UTR of EEF1A2 mRNA, during dif-
ferentiation suggests a potential role of microRNAs in
the eEF1A2 induction during myoblast differentiation
[50]. 
Next, we have examined the role of miRNAs in the
control of eEF1A2 expression in the MCF7 cell line mo- 
del. Our findings demonstrate that two miRNAs, miR-
663 and miR-744, target translation of EEF1A mRNA,
and mediate inhibition of eEF1A2 expression on mRNA
and protein level that results in down-regulation of
MCF7 cells proliferation. Our data also show that the
resveratrol-induced inhibition of breast cancer progres- 
sion can be partially explained by a stimulatory effect
of this treatment on miR-663 and miR-744 expression,
which in turn leads to eEF1A2 downregulation (Submit- 
ted). A separate line of our investigations on eEF1A in-
volvement in tumor formation was directed to under-
standing the prostate tumor-inducing oncogene (PTI-1) 
impact. PTI-1 presumably encoding a truncated form of
eEF1A, was discovered as a gene overexpressed in pro- 
state tumor samples and absent in normal tissues. The
mechanism of PTI-1 oncogenicity remained obscure.
We characterized N-terminus-truncated form of eEF1A 
as analogue of PTI-1 oncogene product. The most signi-
ficant difference between this analogue of PTI-1 and
native eEF1A consists in decreased activity in cell-free
translational system and increased ability to induce
inaccuracy of translation [51]. 
However, despite the detection of the PTI-1 trans-
cript in different cells and tissues, there are no reports
so far about the presence of a protein product of this
gene in the same samples [52]. That is why we put for-
ward a new hypothesis of the PTI-1 oncogenicity based
on the possibility of synthesis of another peptide from
upstream open reading frame in the 5'UTR of the PTI-1
transcript in more favorable context for translation ini-
tiation than the main ORF. 
Importantly, in such case this assumed peptide re-
sembles the active center of relaxin, the peptide hormo- 
ne involved in the prostate cancer progression [53].
However, as much as this idea is attractive it needs a cre-
dible experimental evidence. 
We analyzed cancer-related behavior of the transla- 
tion elongation factor 1H complex (eEF1H) and found
the individual subunits can exist separately from the
eEF1B complex in cancer tissues and that disintegra-
tion of eEF1B could be an important sign of cancer de-
velopment. Nuclear localization of Bγ in both normal
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and cancer tissues suggests its previously unknown nuc-
leus-specific role in human cells [54].
The ribosome is a main body («soma») of the trans-
lational machine and its properties are of great impor-
tance for the effective and correct protein biosynthesis.
Ribosomes from eukaryotes differ in their size, sequen- 
ce, structure, and the ratio of protein to RNA from bac-
teria and archaea. However, there are principal common
features determining molecular mechanisms of initia-
tion, elongation and termination of polypeptide chains.
One of them is a number of tRNA binding sites. In col-
laboration with the laboratory of prof. Kirrilov we were 
the first to show that in spite of considerable differen-
ces between prokaryotic and eukaryotic ribosomes they
are similar in both the number of tRNA binding sites (na-
mely the A, P and E sites) and their distribution between
ribosomal subunits [55]. The 80S ribosome was found
to have two binding sites for aminoacyl-tRNA and pep- 
tidyl-tRNA and the third site formed by its 60S subunit
for deacylated tRNA. The evidence was obtained that
tRNA binding to the A and P sites of 80S ribosomes and 
40S subunits was a cooperative process. The affinity of
tRNA for the A site of 80S ribosome was shown to de-
pend on the correct codon-anticodon pairing at the P
site. This suggests that the cooperativity results from the
codon-induced interaction of tRNA molecules bound
at the A and P sites of 80S ribosomes [56].
One more specific feature of 80S ribosomes from
higher eukaryotic organisms is an ability to hydrolyse
ATP and GTP without the addition of soluble protein
factors. ATPase seems to be an intrinsic activity of the
80S ribosome though this phenomenon is not yet clari-
fied completely. We revealed that as far as wide subst-
rate specificity and possible participation in tRNA inter-
action with the ribosome are concerned, the ribosomal
ATPase seems to be similar to EF-3 found in fungi [57]. 
Further research confirmed that the intrinsic ribosomal
ATPase fulfills the same function as the essential third
elongation factor EF-3, an ATPase in higher fungi, that
facilitates the release of the deacylated tRNA from the
E site of 80S ribosome [58]. It is noteworthy that there
is the reciprocal linkage between the A and E sites of out-
most importance for accurate protein synthesis as the E
site occupation induces a low affinity mode for tRNA
binding to the A site and vice versa, occupation of the A 
site triggers the release of the E site-tRNA. In collabo-
ration with K. Nierhaus this was found true for higher
eukaryotic ribosomes which permits us to conclude
that the allosteric interaction of A and E sites is univer-
sal since it has also been demonstrated in a bacterial and
yeast systems [59]. 
However, in this work we discovered some essen-
tial differences in tRNA and mRNA binding capabili-
ties of eukaryotic and bacterial ribosomes and their su-
bunits. We also found that eukaryotic ribosomes bind
tetracycline with an affinity 15 times lower than that of
bacterial ribosomes. The drug does not affect enzyma-
tic A site occupation of 80S ribosomes in contrast to
non-enzymatic tRNA binding to the A site. Both obser- 
vations explain the relative resistance of eukaryotic ri-
bosomes to this antibiotic. Recently, multiparticle cryo-
electron microscopy and single-molecule FRET investi- 
gations of the mammalian pre-translocation complex
conducted in collaboration with Christian Spahn’s labo-
ratory revealed critical distinctions in the structural and 
energetic features of bacterial and mammalian riboso-
mes, providing a mechanistic basis for divergent trans-
lation regulation strategies and species-specific antibio-
tic action [60].
In summary, our long-term research revealed some
essential specific properties of both translational machi-
ne and process of protein biosynthesis itself in higher
eukaryotes. Among them of special importance are adap-
tation of tRNAs and ARSs cellular pools to the synthe-
sis of specific proteins and its importance for the trans-
lation regulation, compartmentalization of the the protein
synthetic apparatus, channeling of aa-tRNA/tRNA in
elongation cycle via formation of non-orthodox multi-
macromolecular complexes, different features of eEF1A
isoforms and discovery of micro-RNA-mediated regu-
lation of proto-oncogenic A2 isoform in cancer cells,
eEF1A2 crystal form and its description, characteriza-
tion of spatial structure of eEF1A2 and 80S ribosomes,
discovery of the third tRNA binding site on mammals ri-
bosomes and the allosteric interaction of the 80S ribo-
somal A and E sites.
Part of the significant results were obtained in close 
collaboration with Profs. S. Kirillov (former USSR),
M. Deutscher (USA), K. Nierhaus (Germany), M. Mi-
rande (France), I. Serdyuk (RF), and A. Harel-Bellan
(France) to whom we are very thankful for support and
encouragement. 
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À. Â. ªëüñüêà, Á. Ñ. Íåã ðóöü êèé, Â. Ô. Øà ëàê, À. À. Â³ñëî âóõ, 
Ä. Î. Âëà ñåí êî, Î. Â. Íî âî ñèëü íà, Ò. Î. Ëó êàø, Ì. Â. Âå ðåì’ºâà
Îñîá ëè âîñò³ á³îñèí òå çó á³ëêà ó âè ùèõ åâ êàð³îò³â
Ðå çþ ìå
Â îãëÿä ï³äñó ìî âà íî íà é âà ãîì³ø³ ðå çóëü òà òè á³ëüø í³æ ñî ðî êà-
ë³òí³õ äîñë³äæåíü îñîá ëè âîñ òåé òðàíñ ëÿö³¿ ó âè ùèõ åâ êàð³îò³â,
ç-ïîì³æ ÿêèõ: 1) â³äêðèò òÿ àäàï òàö³¿ êë³òèí íèõ ïóë³â òÐÍÊ ³
àì³íî à öèë-òÐÍÊ ñèí òå òàç (ÀÐÑàç) äî ñèí òå çó ñïå öèô³÷íèõ á³ë-
ê³â ³ ìî äó ëÿö³¿ øâèä êîñò³ åëîí ãàö³¿ ð³äê³ñíè ìè ³çî àê öåï òîð íè ìè
òÐÍÊ; 2) âèç íà ÷åí íÿ øà ïå ðî íî ïîä³áíèõ âëàñ òè âîñ òåé êîì ïî -
íåíò³â àïà ðà òó òðàíñ ëÿö³¿ (ðè áî ñîì ³ ôàê òî ðà åëîí ãàö³¿ eEF1A),
õà ðàê òå ðèñ òè êà âè ñî êî ìî ëå êó ëÿð íèõ êîì ïëåêñ³â ÀÐÑàç; 3) âñòà -
íîâëåí íÿ ôóíêö³îíàëü íî¿ êîì ïàð òìåí òàë³çàö³¿, ó òîìó ÷èñë³ êàíà-
ëþ âàí íÿ òÐÍÊ â åâ êàð³îò íèõ êë³òè íàõ; 4) ç’ÿ ñó âàí íÿ ìî ëå êó ëÿð -
íèõ ìå õàí³çì³â êà íà ëþ âàí íÿ, ùî â³äáó âàºòüñÿ çà ïî ñå ðåä íèö òâîì
ð³çíèõ íå êà íîí³÷íèõ êîì ïëåêñ³â, ÿê³ ì³ñòÿòü eEF1A, òÐÍÊ ³ ÀÐÑ-
àçè; 5) õà ðàê òå ðèñ òè êà êðèñ òàë³÷íî¿ ñòðóê òó ðè eEF1A2; 6) ïî-
ð³âíÿí íÿ ïðî ñòî ðî âî¿ îðãàí³çàö³¿, ìî ëå êó ëÿð íî¿ äè íàì³êè, òè ðî -
çè íî âî ãî ôîñ ôî ðè ëþ âàí íÿ ³ çäàò íîñò³ äî âçàºìîä³¿ ç ð³çíè ìè á³ë-
êàìè – ïàð òíå ðà ìè ³çî ôîðì eEF1A1 i eEF1A2; 7) âè ÿâ ëåí íÿ ðîë³
ì³êðîÐÍÊ ó êîí òðîë³ åêñïðåñ³¿ ïðî òî îí êî ãåí íî¿ ³çî ôîð ìè eEF1A2
â ðà êî âèõ êë³òè íàõ; 8) âèâ ÷åí íÿ ñïðè ÷è íå íèõ ðà êîì çì³í êîì ïëåê -
ñó ôàê òîð³â åëîí ãàö³¿ òðàíñ ëÿö³¿ eEF1H ³ ìå õàí³çì³â ä³¿ îíêî ãå íó
PTI-1; 9) â³äêðèò òÿ òðåòü î ãî ñàé òà çâ’ÿ çó âàí íÿ òÐÍÊ ó ðè áî ñî-
ìàõ ññàâö³â òà àëîñ òå ðè÷ íî¿ âçàºìîä³¿ À- ³ Å-ñàéò³â 80S ðè áî ñîìè.
 Êëþ ÷îâ³ ñëî âà: á³îñèí òåç á³ëêà, âèù³ åâ êàð³îòè, òÐÍÊ, àì³-
íî à öèë-òÐÍÊ ñèí òå òà çè, êîì ïàð òìåí òàë³çàö³ÿ, êà íà ëþ âàí íÿ,
eEF1A, ì³êðîÐÍÊ, eEF1H, ÐÒ²-1, 80S ðè áî ñî ìè.
À. Â. Åëüñêàÿ, Á. Ñ. Íåã ðóö êèé, Â. Ô. Øà ëàê, À. À. Âèñ ëî âóõ, 
Ä. Î. Âëà ñåí êî, À. Â. Íî âî ñèëü íàÿ, Ò. Î. Ëó êàø, Ì. Â. Âå ðåìü å âà
Îñî áåí íîñ òè áè î ñèí òå çà áåë êà ó âû ñøèõ ýó êà ðè î ò
Ðå çþ ìå
Â îá çî ðå ñóì ìè ðî âà íû íà è áî ëåå çíà ÷è ìûå ðå çóëü òà òû áî ëåå ÷åì
ñî ðî êà ëåò íå ãî èñ ñëå äî âà íèÿ îñî áåí íîñ òåé òðàíñ ëÿ öèè ó âû ñøèõ
ýó êà ðè î òîâ, ñðå äè íèõ: 1) îò êðû òèå àäàï òà öèè êëå òî÷ íûõ ïó ëîâ 
òÐÍÊ è àìè íî à öèë-òÐÍÊ ñèí òå òàç (ÀÐÑàç) ê ñèí òå çó ñïå öè ôè -
÷åñ êèõ áåë êîâ è ìî äó ëÿ öèè ñêî ðîñ òè ýëîí ãà öèè ðåä êè ìè èçî àê öåï -
òîðíû ìè òÐÍÊ; 2) îïðå äå ëå íèå øà ïå ðî íî ïî äîá íûõ ñâîéñòâ êîì-
ïî íåí òîâ àï ïà ðà òà òðàíñ ëÿ öèè (ðè áî ñîì è ôàê òî ðà ýëîí ãà öèè
eEF1A) è õà ðàê òå ðèñ òè êà âû ñî êî ìî ëå êó ëÿð íûõ êîì ïëåê ñîâ ÀÐÑàç;
3) óñòà íîâ ëå íèå ôóíê öè î íàëü íîé êîì ïàð òìåí òà ëè çà öèè, âêëþ -
÷à þ ùåé êà íà ëè ðî âà íèå òÐÍÊ â ýó êà ðè îò íûõ êëåò êàõ; 4) âû ÿñ íå-
íèå ìî ëå êó ëÿð íûõ ìå õà íèç ìîâ êà íà ëè ðî âà íèÿ, îïîñ ðå äî âàí íî ãî íå-
êàíî íè ÷åñ êè ìè êîì ïëåê ñà ìè, ñî äåð æà ùè ìè eEF1A, òÐÍÊ è ÀÐÑ-
àçû; 5) õà ðàê òå ðèñ òè êà êðèñ òàë ëè ÷åñ êîé ñòðóê òó ðû eEF1A2; 6)
ñðàâ íå íèå ïðî ñòðà íñòâåí íîé îðãà íè çà öèè, ìî ëå êó ëÿð íîé äè íà -
ìè êè, òè ðî çè íî âî ãî ôîñ ôî ðè ëè ðî âà íèÿ è ñïî ñîá íîñ òè ê âçà è ìî -
äåéñòâèþ ñ ðàç ëè÷ íû ìè áåë êà ìè – ïàð òíå ðà ìè èçî ôîðì eEF1A1
è eEF1A2; 7) âû ÿâ ëå íèå ðîëè ìèê ðîÐÍÊ â êîí òðî ëå ýêñ ïðåñ ñèè
ïðî òî îí êî ãåí íîé èçî ôîð ìû eEF1A2 â ðà êî âûõ êëåò êàõ; 8) èç ó÷å -
íèå ñâÿ çàí íûõ ñ ðà êîì èç ìå íå íèé êîì ïëåê ñà ôàê òî ðîâ ýëîí ãà öèè
òðàíñ ëÿ öèè eEF1H è ìå õà íèç ìîâ äå éñòâèÿ îíêî ãå íà ÐÒ²-1; 9) îò -
êðû òèå òðåòü å ãî ñàé òà ñâÿ çû âà íèÿ òÐÍÊ â ðè áî ñî ìàõ ìëå êî ïè -
òà þ ùèõ è àë ëîñ òå ðè ÷åñ êî ãî âçà è ìî äå éñòâèÿ À- è Å-ñàé òîâ íà
80S ðè áî ñî ìàõ.
Êëþ ÷å âûå ñëî âà: áè î ñèí òåç áåë êà, âû ñøèå ýó êà ðè î òû, òÐÍÊ, 
àìè íî à öèë-òÐÍÊ ñèí òå òà çû, êîì ïàð òìåí òà ëè çà öèÿ, êà íà ëè ðî -
âà- íèå, eEF1A, ìèê ðîÐÍÊ, eEF1H, ÐÒ²-1, 80S ðè áî ñî ìû.
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